Hiroyuki Aburatani

83.1k total citations · 6 hit papers
531 papers, 38.1k citations indexed

About

Hiroyuki Aburatani is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hiroyuki Aburatani has authored 531 papers receiving a total of 38.1k indexed citations (citations by other indexed papers that have themselves been cited), including 379 papers in Molecular Biology, 104 papers in Oncology and 104 papers in Cancer Research. Recurrent topics in Hiroyuki Aburatani's work include Epigenetics and DNA Methylation (84 papers), RNA modifications and cancer (47 papers) and Cancer-related gene regulation (47 papers). Hiroyuki Aburatani is often cited by papers focused on Epigenetics and DNA Methylation (84 papers), RNA modifications and cancer (47 papers) and Cancer-related gene regulation (47 papers). Hiroyuki Aburatani collaborates with scholars based in Japan, United States and United Kingdom. Hiroyuki Aburatani's co-authors include Shuichi Tsutsumi, Tatsuhiko Kodama, Akira Watanabe, Masashi Fukayama, Masayuki Yamamoto, Toshiro Niki, Yoshiro Maru, Sachie Hiratsuka, Hozumi Motohashi and Genta Nagae and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Hiroyuki Aburatani

526 papers receiving 37.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

2007 4.0k citations Yuichi Ishikawa, Hiroyuki Aburatani et al. profile →
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming

2012 1.1k citations Hiroyuki Aburatani et al. profile →
Cohesin mediates transcriptional insulation by CCCTC-binding factor

2008 900 citations Shuichi Tsutsumi, Genta Nagae et al. profile →
Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis

2006 808 citations Akira Watanabe, Hiroyuki Aburatani et al. profile →
Copy number variation: New insights in genome diversity

2006 592 citations Hiroyuki Aburatani et al. profile →
The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase

2008 513 citations Akira Watanabe, Hiroyuki Aburatani et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroyuki Aburatani Japan	98	24.4k	8.4k	7.6k	6.1k	4.0k	531	38.1k
Scott L. Pomeroy United States	49	27.9k 1.1×	6.7k 0.8×	9.8k 1.3×	6.3k 1.0×	6.3k 1.6×	117	44.5k
Erik Larsson Sweden	56	21.9k 0.9×	8.3k 1.0×	9.7k 1.3×	6.9k 1.1×	3.7k 0.9×	208	34.1k
Amanda G. Paulovich United States	40	26.0k 1.1×	7.0k 0.8×	8.3k 1.1×	5.6k 0.9×	6.3k 1.6×	87	40.1k
Michael A. Gillette United States	26	25.8k 1.1×	6.5k 0.8×	8.4k 1.1×	6.1k 1.0×	6.1k 1.5×	45	40.3k
William C. Hahn United States	101	26.5k 1.1×	11.2k 1.3×	7.8k 1.0×	4.9k 0.8×	4.7k 1.2×	293	40.9k
Aravind Subramanian United States	29	29.6k 1.2×	7.6k 0.9×	9.9k 1.3×	7.1k 1.2×	7.2k 1.8×	53	45.9k
Gerry Melino Italy	97	22.1k 0.9×	11.0k 1.3×	7.1k 0.9×	4.1k 0.7×	3.5k 0.9×	625	36.9k
Robert J. Coffey United States	98	16.7k 0.7×	7.8k 0.9×	6.4k 0.8×	4.0k 0.7×	2.8k 0.7×	416	34.1k
Takashi Takahashi Japan	96	19.7k 0.8×	11.2k 1.3×	9.0k 1.2×	6.3k 1.0×	6.1k 1.5×	699	37.1k
Jerry W. Shay United States	118	35.3k 1.4×	8.9k 1.1×	4.9k 0.6×	3.5k 0.6×	4.3k 1.1×	522	58.0k

Countries citing papers authored by Hiroyuki Aburatani

Since Specialization

Citations

This map shows the geographic impact of Hiroyuki Aburatani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Aburatani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Aburatani more than expected).

Fields of papers citing papers by Hiroyuki Aburatani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Aburatani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Aburatani. The network helps show where Hiroyuki Aburatani may publish in the future.

Co-authorship network of co-authors of Hiroyuki Aburatani

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Aburatani. A scholar is included among the top collaborators of Hiroyuki Aburatani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Aburatani. Hiroyuki Aburatani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hayashi, Gosuke, Hiroki Ueda, Satoshi Ota, et al.. (2021). Base-resolution analysis of 5-hydroxymethylcytidine by selective oxidation and reverse transcription arrest. Organic & Biomolecular Chemistry. 19(29). 6478–6486. 2 indexed citations

Hokari, Satoshi, Yusuke Tamura, Atsushi Kaneda, et al.. (2019). Comparative analysis of TTF‐1 binding DNA regions in small‐cell lung cancer and non‐small‐cell lung cancer. Molecular Oncology. 14(2). 277–293. 22 indexed citations

Tatsuno, Kenji, Yutaka Midorikawa, Tadatoshi Takayama, et al.. (2019). Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection. Clinical Cancer Research. 25(20). 6217–6227. 26 indexed citations

Matsusaka, Keisuke, Shumpei Ishikawa, Tetsuo Ushiku, et al.. (2016). Tumor Content Chart-Assisted HER2/CEP17 Digital PCR Analysis of Gastric Cancer Biopsy Specimens. PLoS ONE. 11(4). e0154430–e0154430. 5 indexed citations

Sasaki, Haruka, Daisuke Kurotaki, Naoki Osato, et al.. (2014). Transcription factor IRF8 plays a critical role in the development of murine basophils and mast cells. Blood. 125(2). 358–369. 49 indexed citations

Osawa, Tsuyoshi, Rika Tsuchida, Masashi Muramatsu, et al.. (2013). Inhibition of Histone Demethylase JMJD1A Improves Anti-Angiogenic Therapy and Reduces Tumor-Associated Macrophages. Cancer Research. 73(10). 3019–3028. 72 indexed citations

Muto, Tomoya, Goro Sashida, Motohiko Oshima, et al.. (2013). Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders. The Journal of Experimental Medicine. 210(12). 2627–2639. 137 indexed citations

Chauhan, Subhash C., Mara C. Ebeling, Diane M. Maher, et al.. (2011). MUC13 Mucin Augments Pancreatic Tumorigenesis. Molecular Cancer Therapeutics. 11(1). 24–33. 77 indexed citations

Matsusaka, Keisuke, Atsushi Kaneda, Genta Nagae, et al.. (2011). Classification of Epstein–Barr Virus–Positive Gastric Cancers by Definition of DNA Methylation Epigenotypes. Cancer Research. 71(23). 7187–7197. 183 indexed citations

10.

Tsuchiya, Naoto, Masashi Izumiya, Hiroko Ogata‐Kawata, et al.. (2011). Tumor Suppressor miR-22 Determines p53-Dependent Cellular Fate through Post-transcriptional Regulation of p21. Cancer Research. 71(13). 4628–4639. 101 indexed citations

11.

Yagi, Koichi, Kiwamu Akagi, Hiroshi Hayashi, et al.. (2009). Three DNA Methylation Epigenotypes in Human Colorectal Cancer. Clinical Cancer Research. 16(1). 21–33. 191 indexed citations

12.

Kayama, Yosuke, Tohru Minamino, Haruhiro Toko, et al.. (2009). Cardiac 12/15 lipoxygenase–induced inflammation is involved in heart failure. The Journal of Experimental Medicine. 206(7). 1565–1574. 128 indexed citations

13.

Takanaga, Hiromi, et al.. (2008). Gli2 Is a Novel Regulator of Sox2 Expression in Telencephalic Neuroepithelial Cells. Stem Cells. 27(1). 165–174. 85 indexed citations

14.

Shimizu, Takeshi, Tetsushi Kagawa, Toshihiro Inoue, et al.. (2008). Stabilized β-Catenin Functions through TCF/LEF Proteins and the Notch/RBP-Jκ Complex To Promote Proliferation and Suppress Differentiation of Neural Precursor Cells. Molecular and Cellular Biology. 28(24). 7427–7441. 156 indexed citations

15.

Takayama, Ken‐ichi, Shuichi Tsutsumi, Takashi Suzuki, et al.. (2008). Amyloid Precursor Protein Is a Primary Androgen Target Gene That Promotes Prostate Cancer Growth. Cancer Research. 69(1). 137–142. 96 indexed citations

16.

Ehata, Shogo, Aki Hanyu, Makoto Hayashi, et al.. (2007). Transforming Growth Factor-β Promotes Survival of Mammary Carcinoma Cells through Induction of Antiapoptotic Transcription Factor DEC1. Cancer Research. 67(20). 9694–9703. 76 indexed citations

17.

Goto, Yasufumi, Yuriko Matsuzaki, Ayako Shimizu, et al.. (2006). A New Melanoma Antigen Fatty Acid–Binding Protein 7, Involved in Proliferation and Invasion, Is a Potential Target for Immunotherapy and Molecular Target Therapy. Cancer Research. 66(8). 4443–4449. 48 indexed citations

18.

Aggarwal, Amit, Yujin Hoshida, Siu Tsan Yuen, et al.. (2006). Topological and Functional Discovery in a Gene Coexpression Meta-Network of Gastric Cancer. Cancer Research. 66(1). 232–241. 69 indexed citations

19.

Vance, David E., et al.. (1997). Role of phosphatidylethanolamine-N-methyltransferase (PEMT) in the development of human hepatocellular carcinoma. The FASEB Journal. 11(9). 1429. 1 indexed citations

20.

Aburatani, Hiroyuki, et al.. (1994). Identification of a region of homozygous deletion in cervical carcinoma. The American Journal of Human Genetics. 55(3). 34–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact